SCHEMBL2312409

SCHEMBL2312409

O=[N+]([O-])c1ccc(Cl)cc1Oc1ccc(F)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPB1 P04792 3/20 0.58
PDE7A Q13946 1/20 0.57
MAPT P10636 3/20 0.51
LMNA P02545 1/20 0.51
HTT P42858 1/20 0.51
CRHBP P24387 1/20 0.50
CRHR2 Q13324 1/20 0.50
TSHR P16473 1/20 0.49
MAPK1 P28482 1/20 0.49
TDP1 Q9NUW8 3/20 0.47
MERTK Q12866 1/20 0.47
ATM Q13315 1/20 0.45
ALDH1A1 P00352 1/20 0.44
GAA P10253 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
TTR P02766 1/20 0.43
ALB P02768 1/20 0.43
THRB P10828 1/20 0.43
EPAS1 Q99814 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28747580 0.91 PDE7A (0.63) HSPB1PDE7AMAPTLMNATSHR
SCHEMBL1299058 0.85 PDE7A (0.57) PDE7AMAPTLMNAHTTTSHR
SCHEMBL9174802 0.84 MEN1 (0.60) PDE7AMAPTLMNATSHRMAPK1
SCHEMBL1242401 0.84 PDE7A (0.53) HSPB1PDE7AMAPTLMNATSHR
SCHEMBL7010562 0.82 PDE7A (0.54) PDE7AMAPTLMNATSHRMAPK1
SCHEMBL25889534 0.82 HSPB1 (0.58) HSPB1PDE7AMAPTLMNAHTT
SCHEMBL10477049 0.80 HSPB1 (0.70) HSPB1PDE7AMAPTLMNAHTT
SCHEMBL28747561 0.79 HTR2A (0.51) HSPB1PDE7AMAPTLMNAHTT
SCHEMBL28360626 0.79 TSHR (0.54) HSPB1PDE7AMAPTLMNAHTT
SCHEMBL1283885 0.79 HSPB1 (0.67) HSPB1MAPTLMNAHTTCRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8642640-B2 1-phenylpyrrole derivatives EXELIXIS, INC. (US) 2014-02-04 US disclosed
EP-2349996-B1 1-PHENYLPYRROLE COMPOUNDS EXELIXIS INC (US) 2014-01-01 EP disclosed
US-20110263544-A1 1-Phenylpyrrole Derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-10-27 US disclosed
EP-2349996-A1 1-PHENYLPYRROLE COMPOUNDS Exelixis, Inc. (US) 2011-08-03 EP disclosed
WO-2010042626-A1 1-PHENYLPYRROLE COMPOUNDS EXELIXIS, INC. (US) 2010-04-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263544-A1 1-Phenylpyrrole Derivatives REN, AGTR1, NR3C2 HSPB1 1404/4885PDE7A 2715/4885MAPT 4844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.